Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank22
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
0.00
↓ 100% vs avg
Percentile
P22
Within normal range
Average
6.67
Historical baseline
PeriodValueYoY Change
20250.00-
20240.00-
20230.00-
20220.00+100.0%
2021-2.30-106.7%
202034.18-4.5%
201935.78+1869.9%
2018-2.02-502.8%
20130.50-10.0%
20120.56-